UGI Seminar 'Mapping the rules of glioblastoma with integrated single cell and spatial genomics'
20 November 2024, 3:00 pm–4:00 pm
UGI Seminar Speaker: Omer Ali Bayraktar, Wellcome Sanger Institute, Hinxton, United Kingdom
Event Information
Open to
- All
Organiser
-
Cenk Celik
UGI Seminar
Wednesday, 20 November at 1500hrs
309 Roberts Building (directions)
Mapping the rules of glioblastoma with integrated single cell and spatial genomics
Abstract: The malignant brain tumour glioblastoma multiforme (GBM) displays significant levels of cellular heterogeneity and plasticity that correlate with patient outcomes. However, we lack fundamental insight on how diverse malignant cell states arise and organise in GBM. Here, I will present GBM-space, a new collaborative effort to map the cellular and tissue architecture of GBM using multi-modal genomics. Deeply profiling 12 tumours across multiple sites, we created the most comprehensive single cell and spatial genomic map of inter- and intratumour heterogeneity to date. Surveying joint RNA and ATAC profiles of over 1 million cells, we expanded the description of recurrent malignant and TME cell states and resolved their gene regulatory networks. Using sequencing and imaging-based spatial transcriptomics, we discovered that malignant cell states regionally segregate into distinct spatial tissue niches in GBM and associate with distinct TMEs. We found that these niches recur across patients and tumour genotypes, reflecting a shared tissue organisation across GBM. Furthermore, we find that that the spatial organisation of malignant cells reflects their stereotyped cellular trajectories from neurodevelopmental-like to injury response and hypoxia states during tumour expansion. Our efforts reveal novel spatial organisation of malignant cell states in glioblastoma across a dominant cellular trajectory.
About the Speaker
Omer Ali Bayraktar
at Wellcome Sanger Institute, Hinxton
Dr Bayraktar uses single cell and spatial transcriptomics technologies to characterize human brain cellular diversity in health and disease. During his training, Omer discovered neural stem cell patterning mechanisms (Nature 2013) and astrocyte layer diversity in the cerebral cortex (Nature Neuro 2020). Omer started his independent research group at the Wellcome Sanger Institute in 2018. His team has developed the cell2location computational tool to map fine cell types in spatial transcriptomics (Nature Biotech 2022). Omer is internationally funded by Wellcome LEAP, SFARI and CZI, and he steers spatial genomic strategy at the Sanger Institute.
More about Omer Ali Bayraktar